The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Human Cannabinoid Pharmacokinetics
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both THC and CBD are predominantly metabolized, by the liver, through the action of the cytochrome P450 system.104,105”
From Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions (2024) · cites this paper as [104]
Citations
Cites
Pharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,514
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Russo, E. B., & Guy, G. W. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 608
Constituents of Cannabis sativa L. XVII. A review of the natural constituents
Turner, C. E., Elsohly, M. A., & Boeren, E. G. (1980) · Journal of Natural Products · doi:10.1021/np50008a001 · Cited by 599
Cannabis: pharmacology and toxicology in animals and humans
Adams, I. B., & Martin, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 576
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J., Brown, P., Pertwee, R., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 546
Research works printed but not linked: 26
- Agurell S., 1971, Acta Pharm. Suecica, 8, 391
- Agurell S., 1986, Pharmacol. Rev., 38, 21
- Azorlosa J. L., 1992, J. Pharmacol. Exper. Ther., 261, 114
- Perez‐Reyes M., 1990, NIDA Res. Monograph, 99, 42
- Harder S., 1997, Int. J. Clin. Pharmacol. Ther., 35, 155
- Ohlsson A., 1981, NIDA Res. Monograph, 34, 250
- Meier H. J., 1997, Schweiz. Med. Wochenschr., 127, 214
- Brenneisen R., 1996, Int. J. Clin. Pharmacol. Ther., 34, 446
- Vinciguerra V., 1988, N. Y. State J. Med., 88, 525
- McArdle K., 2001, Toxicology, 168, 133
- Garrett E. R., 1978, Adv. Biosci., 22, 105
- Hunt C. A., 1980, J. Pharmacol. Exper. Ther., 215, 35
- Lee C. C., 1985, NIDA Res. Monograph, 60, 110
- Martin B. R., 1977, Res. Commun. Chem. Pathol. Pharmacol., 17, 457
- Ben‐Zvi Z., 1974, Res. Commun. Chem. Pathol. Pharmacol., 8, 223
- Harvey D. J., 1986, Rev. Biochem. Toxicol., 6, 221
- Bornheim L. M., 1992, Drug Metab. Dispos., 20, 241
- Halldin M. M., 1982, Drug Metab. Dispos., 10, 297
- Chiang C. N., 1987, NIDA Res. Monograph
- Bloom A. S., 1982, J. Pharmacol. Exper. Ther., 221, 97
- Green M. D., 1997, Drug Metab. Dispos., 25, 1389
- Mura P., 1999, Acta Clin. Belg., 1, 35
- Soares J. R., 1982, NIDA Res. Monograph, 42, 44
- Hawks R. L., 1982, NIDA Res. Monograph, 42, 125
- Huestis M. A., 1992, Am. Acad. Forensic Sci. Annual Meeting, 190
- Balabanova S., 1989, Beitr. Gerichtl. Med., 48, 45
Cited by
Sorted by citations
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
The pharmacokinetics and the pharmacodynamics of cannabinoids
Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724
Practical considerations in medical cannabis administration and dosing
MacCallum, C. A., & Russo, E. B. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.01.004 · Cited by 663
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Millar, S., Stone, N. L., Yates, A. S., & O’Sullivan, S. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01365 · Cited by 604
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Devinsky, O., Patel, A. D., Thiele, E. A., Wong, M. H., Appleton, R. T., Harden, C. L., Greenwood, S. M., Morrison, G., Sommerville, K. W., On behalf of the GWPCARE1 Part A Study Group, et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005254 · Cited by 478
Metadata
- Authors
- Huestis, M. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Huestis, Marilyn A.
- ORCID
- Huestis, Marilyn A.
- Venue
- Chemistry & Biodiversity
- Publisher
- Wiley
- Published
- 2007-08
- Volume
- 4
- Issue
- 8
- Pages
- 1770-1804
- ISSN
- 1612-1872 (ISSN-L)
- 1612-1880
- PMC
- PMC2689518
- OpenAlex
- W2169754532
- Cited by
- 1,102
- References
- 173
- Citations by year
- 2026: 79 · 2025: 97 · 2024: 77 · 2023: 114 · 2022: 109 · 2021: 121 · 2020: 132 · 2019: 117 · 2018: 70 · 2017: 56 · 2016: 42 · 2015: 31 · 2014: 14 · 2013: 13 · 2012: 10
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Chemistry & Biodiversity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (Z01DA000413, Z01DA000415, Z01DA000412)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- cannabinoids, pharmacokinetics, human metabolism, drug absorption, distribution, metabolism, excretion
- MeSH terms
- Cannabinoids, Humans, Sweat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
